Yehuda Handelsman

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Ankylosing Spondylitis

Acute Heart Failure

Top Venues

Diabetes/metabolism research and reviews

Advances in therapy

Vascular health and risk management

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H Eckel, Luc Van Gaal, Peter Haulund Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Paolo Pozzilli, Stephano Del Prato, Francesco Prattichizzo, Oliver Schnell, Petar M Seferović, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez
Cardio-renal-metabolic disease in primary care setting. Diabetes/metabolism research and reviews 40 (3) (2023)
Daniel A Duprez, Yehuda Handelsman, Michael Koren
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects. Vascular health and risk management 16 (2020)
Yehuda Handelsman, Marcel H A Muskiet, Graydon S Meneilly
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine. Advances in therapy 36 (12) (2019)
Yehuda Handelsman
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes. Advances in therapy 36 (10) (2019)
Yehuda Handelsman, Chantal Mathieu, Stephano Del Prato, Eva Johnsson, Raisa Kurlyandskaya, Nayyar Iqbal, Ricardo Garcia-Sanchez, Julio Rosenstock
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes. Diabetes, obesity & metabolism 21 (4) (2019)